These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Structure and activity relationships of monoamine oxidase inhibitors. BIEL JH; NUHFER PA; CONWAY AC Ann N Y Acad Sci; 1959 Sep; 80():568-82. PubMed ID: 13800538 [No Abstract] [Full Text] [Related]
24. [Monoamine oxidase inhibitors--a new group of drugs?]. NAESS K Nord Med; 1959 Aug; 62():1251-5. PubMed ID: 14425748 [No Abstract] [Full Text] [Related]
25. Behavioral determination of time and dose parameters of monoamine oxidase inhibitors. HEISE GA; BOFF E J Pharmacol Exp Ther; 1960 Jun; 129():155-62. PubMed ID: 14400778 [No Abstract] [Full Text] [Related]
26. Clinical and pharmacological considerations on mode of action of monoamine oxidase inhibitors. ZBINDEN G; RANDALL LO; MOE RA Dis Nerv Syst; 1960 Mar; 21(3)Suppl():89-100. PubMed ID: 13855472 [No Abstract] [Full Text] [Related]
27. Cardiac activities of several monoamine oxidase inhibitors. LEE WC; SHIN WH; SHIDEMAN FE J Pharmacol Exp Ther; 1961 Aug; 133():180-5. PubMed ID: 13760280 [No Abstract] [Full Text] [Related]
28. The pharmacological evaluation of monoamine oxidase inhibitors. LESSIN AW Biochem Pharmacol; 1959 Nov; 2():290-8. PubMed ID: 14416030 [No Abstract] [Full Text] [Related]
29. Intracellular distribution of norepinephrine in rat brain. I. Effect of reserpine and the monoamine oxidase inhibitors, trans-2-phenylcyclopropylamine and 1-isonicotinyl-2-isopropyl hydrazine. GREEN H; SAWYER JL J Pharmacol Exp Ther; 1960 Jul; 129():243-9. PubMed ID: 13851489 [No Abstract] [Full Text] [Related]
30. A method for measurement of monoamine oxidase inhibition in man: application to studies on hypertension. SJOERDSMA A; GILLESPIE L; UDENFRIEND S Ann N Y Acad Sci; 1959 Sep; 80():969-80. PubMed ID: 13831423 [No Abstract] [Full Text] [Related]
31. Significance of monoamine oxidase inhibition for the pharmacological and clinical effects of hydrazine derivatives. PLETSCHER A Ann N Y Acad Sci; 1959 Sep; 80():1039-45. PubMed ID: 14433482 [No Abstract] [Full Text] [Related]
33. Clinical application of the monoamine oxidase inhibitors in cardiovascular disease. GRIFFITH GC Dis Nerv Syst; 1960 Mar; 21(3)Suppl():101-3. PubMed ID: 13829305 [No Abstract] [Full Text] [Related]
34. [On the activity of adrenalin, noradrenalin and monoamine oxidase inhibitors administered directly into the reticular formation of the brain stem by means of a micro-injection method]. TRZEBSKI A Acta Physiol Pol; 1960; 11():905-7. PubMed ID: 13778310 [No Abstract] [Full Text] [Related]
35. Anticonvulsant properties of monoamine oxidase inhibitors. PROCKOP DJ; SHORE PA; BRODIE BB Ann N Y Acad Sci; 1959 Sep; 80():643-51. PubMed ID: 14434994 [No Abstract] [Full Text] [Related]
39. Monoamine oxidase inhibitors and procedures for their evaluation in vivo and in vitro. OZAKI M; WEISSBACH H; OZAKI A; WITKOP B; UDENFRIEND S J Med Pharm Chem; 1960 Dec; 2():591-607. PubMed ID: 13731832 [No Abstract] [Full Text] [Related]
40. The mode of action of monoamine oxidase inhibitors with special reference to serotonin. CRUMPTON CW Am J Cardiol; 1960 Dec; 6():1117-20. PubMed ID: 13718638 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]